Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Radical prostatectomy for high-risk prostate cancer | Opinion: NO.

Ghodoussipour S, Cacciamani GE, Abreu ALC.

Int Braz J Urol. 2019 May-Jun;45(3):428-434. doi: 10.1590/S1677-5538.IBJU.2019.03.03. No abstract available.


Radical prostatectomy for high-risk prostate cancer | Opinion: YES.

Reis LO, Montenegro R, Trinh QD.

Int Braz J Urol. 2019 May-Jun;45(3):424-427. doi: 10.1590/S1677-5538.IBJU.2019.03.02. No abstract available.


Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?

Nagao K, Matsuyama H, Matsumoto H, Nasu T, Yamamoto M, Kamiryo Y, Baba Y, Suga A, Tei Y, Yoshihiro S, Aoki A, Shimabukuro T, Joko K, Sakano S, Takai K, Yamaguchi S, Akao J, Kitahara S; Yamaguchi Uro-Oncology Group.

Int J Clin Oncol. 2018 Aug;23(4):757-764. doi: 10.1007/s10147-018-1272-9. Epub 2018 Mar 27.


[Radical prostatectomy and radiation therapy for high-risk prostate cancer: An update].

Lei JH, Chen YJ, Liu LR, Wei Q.

Zhonghua Nan Ke Xue. 2015 Jul;21(7):663-6. Chinese.


Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes.

Costa WH, Guimarães GC.

Int Braz J Urol. 2016 Sep-Oct;42(5):876-879. doi: 10.1590/S1677-5538.IBJU.2016.05.04. No abstract available.


Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: validation of recently released criteria.

Gandaglia G, Karakiewicz PI, Briganti A, Trudeau V, Trinh QD, Kim SP, Montorsi F, Nguyen PL, Abdollah F, Sun M.

Int J Urol. 2015 Jan;22(1):89-95. doi: 10.1111/iju.12605. Epub 2014 Aug 21.


High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.

Savdie R, Horvath LG, Benito RP, Rasiah KK, Haynes AM, Chatfield M, Stricker PD, Turner JJ, Delprado W, Henshall SM, Sutherland RL, Kench JG.

BJU Int. 2012 Jun;109(12):1794-800. doi: 10.1111/j.1464-410X.2011.10572.x. Epub 2011 Oct 12.


Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site.

Papachristofilou A, Zimmermann F.

BJU Int. 2013 Apr;111(4):E142-3. doi: 10.1111/j.1464-410X.2013.11397_9.x. No abstract available.


Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.

Johnson SB, Hamstra DA, Jackson WC, Zhou J, Foster B, Foster C, Song Y, Li D, Palapattu GS, Kunju L, Mehra R, Sandler H, Feng FY.

Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):275-81. doi: 10.1016/j.ijrobp.2013.05.043. Epub 2013 Jul 23.


Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup.

Moschini M, Sharma V, Zattoni F, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Kwon ED, Karnes RJ.

J Urol. 2016 Jun;195(6):1773-8. doi: 10.1016/j.juro.2015.12.074. Epub 2015 Dec 23.


Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.

Nieder AM, Porter MP, Soloway MS.

J Urol. 2008 Nov;180(5):2005-9; discussion 2009-10. doi: 10.1016/j.juro.2008.07.038. Epub 2008 Sep 17.


Radical prostatectomy after radiotherapy for prostatic cancer.

Carson CC 3rd, Zincke H, Utz DC, Cupps RE, Farrow GM.

J Urol. 1980 Aug;124(2):237-9.


Defining prostate cancer risk after radical prostatectomy.

Adamis S, Varkarakis IM.

Eur J Surg Oncol. 2014 May;40(5):496-504. doi: 10.1016/j.ejso.2014.02.221. Epub 2014 Feb 20. Review.


Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.

Perlis N, Sayyid R, Evans A, Van Der Kwast T, Toi A, Finelli A, Kulkarni G, Hamilton R, Zlotta AR, Trachtenberg J, Ghai S, Fleshner NE.

J Urol. 2017 Jan;197(1):75-83. doi: 10.1016/j.juro.2016.07.076. Epub 2016 Jul 22.


Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging.

Song SH, Pak S, Park S, Song C, Jeong IG, Choi HJ, Kim JK, Cho KS, Kim CS, Ahn H.

J Urol. 2014 Aug;192(2):402-8. doi: 10.1016/j.juro.2014.02.2568. Epub 2014 Mar 11.


Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy.

Beauval JB, Ploussard G, Cabarrou B, Roumiguié M, Ouzzane A, Gas J, Goujon A, Marcq G, Mathieu R, Vincendeau S, Cathelineau X, Mongiat-Artus P, Salomon L, Soulié M, Méjean A, de La Taille A, Rouprêt M, Rozet F; Committee of Cancerology of the Association of French Urology.

World J Urol. 2017 Aug;35(8):1191-1197. doi: 10.1007/s00345-016-1979-z. Epub 2016 Dec 16.


Comparison of biochemical recurrence in prostate cancer patients treated with radical prostatectomy or radiotherapy.

Kim DS, Jeon SH, Chang SG, Lee SH.

Korean J Urol. 2015 Oct;56(10):703-9. doi: 10.4111/kju.2015.56.10.703. Epub 2015 Oct 2.


Radical Prostatectomy for High-risk Localized or Node-Positive Prostate Cancer: Removing the Primary.

Matulay JT, DeCastro GJ.

Curr Urol Rep. 2017 Jul;18(7):53. doi: 10.1007/s11934-017-0703-x. Review.


Difference of opinion - Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: Yes.

van der Poel HG, van den Bergh RC.

Int Braz J Urol. 2016 May-Jun;42(3):413-7. doi: 10.1590/S1677-5538.IBJU.2016.03.03. No abstract available.


Safety of selective nerve sparing in high risk prostate cancer during robot-assisted radical prostatectomy.

Kumar A, Samavedi S, Bates AS, Mouraviev V, Coelho RF, Rocco B, Patel VR.

J Robot Surg. 2017 Jun;11(2):129-138. doi: 10.1007/s11701-016-0627-3. Epub 2016 Jul 19.


Supplemental Content

Support Center